EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality

Jay Kakadiya iD, Pranjal Rai iD, Girish Bathla iD, Vidhi Dhaduk iD, Huanwen Chen iD, Matthew K McIntyre iD, Daniel Mandel iD, Shahrzad Latifi iD, Brian Connolly, Hamza A Salim iD, Ahmed Y Azzam iD, Muhammed Amir Essibayi iD und 8 weitere

Journal of Clinical Neurology · 2026 · 22 (5) · 540

DOI: 10.3988/jcn.2026.0073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Neurology, 2026. Verfasst von Jay Kakadiya und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroradiology, Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: A transient ischemic attack (TIA) is associated with a markedly higher risk of subsequent ischemic stroke even when guideline-directed prevention strategies are applied. There is evidence emerging from the LAMP trial that glucagon-like peptide-1 receptor agonists (GLP-1RAs) can help to prevent secondary stroke. We therefore conducted this study to evaluate the association in a real-world cohort. METHODS: We conducted a retrospective cohort study using data from the TriNetX US Collaborative Network. Adults with TIA who received antithrombotic therapy between 7 days before and 7 days after a TIA diagnosis were included. GLP-1RA use was defined as its initiation between 3 months before to 7 days after a TIA diagnosis. Propensity-score matching (PSM) was performed at a 1:1 ratio to balance covariates. The primary outcomes were ischemic stroke and mortality, while the secondary outcomes were inpatient (IP) admissions and emergency department (ED) visits. Outcomes were assessed over a 5-year follow-up period. Sensitivity analyses stratified by body mass index, hemoglobin-A1c level, and atrial fibrillation status were conducted to generalize the findings. RESULTS: After applying PSM, 5,071 GLP-1RA users and 5,071 GLP-1RA nonusers were included. GLP-1RA use was associated with lower risks of ischemic stroke (6.9% vs. 10.9%, hazard ratio [HR]=0.76, p

Schlagwörter

Stichwörter der Autor:innen

TriNetXglucagon-like peptide-1 receptor agonistsischemic strokemortalitytransient ischemic attack

Autor:innen und Institutionen

  • Division of Neuroradiology, Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Department of Neurology, Shantabaa Medical College and General Hospital, Amreli, Gujarat, India.
  • Department of Neurosurgery, University of Maryland Medical Center, Baltimore, MD, USA.
  • Department of Neurosurgery, Oregon Health and Science University, Portland, OR, USA.
  • Department of Neurology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA.

ORCID-Profile: Jay Kakadiya, Pranjal Rai, Girish Bathla, Vidhi Dhaduk, Huanwen Chen, Matthew K McIntyre, Daniel Mandel, Shahrzad Latifi, Hamza A Salim, Ahmed Y Azzam, Muhammed Amir Essibayi, Vivek S Yedavalli, Majid Khan, Adam A Dmytriw, David J Altschul, Marco Colasurdo, Ajay Malhotra, Dheeraj Gandhi, Dhairya A Lakhani

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Kakadiya, J., Rai, P., Bathla, G., Dhaduk, V., Chen, H., McIntyre, M. K., Mandel, D., Latifi, S., Connolly, B., Salim, H. A., Azzam, A. Y., Essibayi, M. A., Yedavalli, V. S., Khan, M., Dmytriw, A. A., Altschul, D. J., Colasurdo, M., Malhotra, A., Gandhi, D., & Lakhani, D. A. (2026). Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality. Journal of Clinical Neurology, 22(5), 540. https://doi.org/10.3988/jcn.2026.0073

Vancouver

Kakadiya J, Rai P, Bathla G, Dhaduk V, Chen H, McIntyre MK, et al. Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality. Journal of Clinical Neurology. 2026;22(5):540. doi:10.3988/jcn.2026.0073

BibTeX
@article{Kakadiya2026,
  author = {Kakadiya, Jay and Rai, Pranjal and Bathla, Girish and Dhaduk, Vidhi and Chen, Huanwen and McIntyre, Matthew K and Mandel, Daniel and Latifi, Shahrzad and Connolly, Brian and Salim, Hamza A and Azzam, Ahmed Y and Essibayi, Muhammed Amir and Yedavalli, Vivek S and Khan, Majid and Dmytriw, Adam A and Altschul, David J and Colasurdo, Marco and Malhotra, Ajay and Gandhi, Dheeraj and Lakhani, Dhairya A},
  title = {Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality},
  journal = {Journal of Clinical Neurology},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {540},
  doi = {10.3988/jcn.2026.0073}
}
Kostenlos starten →